To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

July 28, 2022

Brain Cancer Spanish Website Launched by Ivy Brain Tumor Center

Ovy brain tumor center logo

"The End Brain Cancer Initiative is proud to announce to the Brain Tumor Community that the Ivy Brain Tumor Center is Increasing Inclusion & Diversity for patients as it relates to treatment options, diagnostic options and clinical trials through their newly launched website in Spanish"

~ Dellann Elliott Mydland, President, The End Brain Cancer Initiative

Ad for spanish website in  spanish
Doctor and patient indiscussion

IvyBrain mirrors the English version of the site and will be regularly updated with the most current clinical trial information, patient support resources, inspiring patient stories, and more. Visitors whose web browsers are set to Spanish will be automatically directed to the Spanish site, while those using English language browsers can visit it at any time at:

Doctor at microscope

"When we originally launched, the website's primary goal was to provide easy-to-understand information about brain cancer, the challenges of treating the disease, and our innovative Phase 0 clinical trial approach. By making that information accessible to the Spanish-speaking community, we aim to enhance diversity in our clinical trials and bring hope to brain tumor patients and families worldwide."

People hugging

This month also marks four years since the Ivy Brain Tumor Center was established. The Ivy Center's multidisciplinary team Of brain tumor specialists and scientists is accelerating drug discovery and precision medicine in neuro-oncology to identify the most promising first-in-class therapies for brain tumor patients.


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram